Evaluation of Sinus Augmentation Bone Healing Using Autograft and Xenograft Compared to Xenograft Alone
Sinus Augmentation Healing With Autogenous and Xenograft Mix Compared to Xenograft Alone
1 other identifier
interventional
10
1 country
1
Brief Summary
To evaluate bone healing at 4 months after lateral sinus augmentation with a 4:1 ratio of autologous bone and xenograft or xenograft alone. A radiographic volumetric, histomorphometric, and histologic analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
January 23, 2026
January 1, 2026
2.7 years
January 30, 2024
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Histological analysis
Mineralized and non-mineralized tissue Remnant particles of biomaterial Inflammatory infiltrate
4 months from surgery
Secondary Outcomes (2)
Volumetric bone analysis 4 months post sinus augmentation
4 months from surgery
Radiographic bone height gain at 4 months
4 months post sinus augmentation
Study Arms (2)
Xenograft - Autogenous 1:4
EXPERIMENTALSinus grafted with a ratio of Xenograft - Autogenous 1:4
Xenograft alone
ACTIVE COMPARATORSinus grafted with Xenograft only
Interventions
Randomised Sinus Lift augmentation either with Xenograft - Autogenous ratio 1:4 (test) or Xenograft alone (Control)
An research only use of CBCT at visit 2 to review healing status.
Eligibility Criteria
You may qualify if:
- Patients of Tufts School of Dental Medicine (TUSDM)
- Two stage sinus augmentations with \<5mm (Zinner, Small 2004) residual bone height in need of augmentation for implant placement
- Full maxillary edentulism or Kennedy class I or III
- to 100 year old
You may not qualify if:
- Adults unable to consent (cognitively impaired adults)
- Those who self-report as pregnant or breastfeeding
- Wards of the state
- Non-Viable neonates
- Neonates of uncertain viability
- \< 18 years of age
- Refusal to participate
- Prior medical condition causing complications in bone metabolism
- Osteoporosis
- History of/or current chemotherapy
- History of/or current head and neck radiation
- Current heavy smoking \> 10 cigarettes/day
- Self-reported pregnancy or lactation
- Previous history of sinus elevation procedure
- Existing sinus pathology or pathology discovered at time of sinus augmentation or implant placement
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Universitylead
Study Sites (1)
Tufts University School of Dental Medicine
Boston, Massachusetts, 02111, United States
Related Publications (3)
Al-Moraissi E, Alhajj WA, Al-Qadhi G, Christidis N. Bone Graft Osseous Changes After Maxillary Sinus Floor Augmentation: A Systematic Review. J Oral Implantol. 2022 Oct 1;48(5):464-471. doi: 10.1563/aaid-joi-D-21-00310.
PMID: 35881815BACKGROUNDAl-Moraissi EA, Alkhutari AS, Abotaleb B, Altairi NH, Del Fabbro M. Do osteoconductive bone substitutes result in similar bone regeneration for maxillary sinus augmentation when compared to osteogenic and osteoinductive bone grafts? A systematic review and frequentist network meta-analysis. Int J Oral Maxillofac Surg. 2020 Jan;49(1):107-120. doi: 10.1016/j.ijom.2019.05.004. Epub 2019 Jun 21.
PMID: 31230768BACKGROUNDBarone A, Crespi R, Aldini NN, Fini M, Giardino R, Covani U. Maxillary sinus augmentation: histologic and histomorphometric analysis. Int J Oral Maxillofac Implants. 2005 Jul-Aug;20(4):519-25.
PMID: 16161735BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Lorenzo Mordini, DDS, MS
Tufts Univeristy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Clinical examiners, study surgeons, and subjects will not be blinded. Analysis of histomorphometric, histologic, and volumetric data will be completed by an external lab and will not be aware of what group the subjects were in.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 7, 2024
Study Start
September 1, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2028
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share